Molecular characterization of drug-resistant Beijing family isolates of mycobacterium tuberculosis from Tianjin, China

Biomedical and Environmental Sciences

Volumn 23, Issue 3, 2010, Pages 188-193

  Li, Gui Lian ^a   Zhao, De Fu ^b   Xie, Tong ^b   Ju, Han Fang ^b   Mu, Cheng ^b   Zhao, Hui ^b   Wang, Xie Xiu ^c  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Tuberculosis Rreference Laboratory   (China)

^c TIANJIN CENTERS FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Beijing family; Drug resistance; Mutation; Mycobacterium tuberculosis

Indexed keywords

MYCOBACTERIUM TUBERCULOSIS;

EID: 77956563612     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-3988(10)60051-7     Document Type: Article

References (45)

1. Githui W A, Jordaan A M, Juma E S, et al. (2004). Identification of MDR-TB Beijing/W and other Mycobacterium tuberculosis genotypes in Nairobi, Kenya. Int J Tuberc Lung Dis 8(3), 352-360.
2. Johnson R, Warren R, Strauss O J, et al. (2006). An outbreak of drug-resistant tuberculosis caused by a Beijing strain in the western Cape, South Africa. Int J Tuberc Lung Dis 10(12), 1412-1414.
3. Affolabi D, Faihun F, Sanoussi N, et al. (2009). Possible outbreak of streptomycin-resistant Mycobacterium tuberculosis Beijing in Benin. Emerg Infect Dis 15(7), 1123-1125.
4. Park Y K, Shin S, Ryu S, et al. (2005). Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea. J Microbiol Methods 63(2), 165-172.
5. Jiao W W, Mokrousov I, Sun G Z, et al. (2007). Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China. Chin Med J (Engl) 120(9), 814-819.
6. Tracevska T, Jansone I, Nodieva A, et al. (2004). Characterisation of rpsL, rrs and embB mutations associated with streptomycin and ethambutol resistance in Mycobacterium tuberculosis. Res Microbiol 155(10), 830-834.
7. Warren R M, Victor T C, Streicher E M, et al.(2004). Patients with active tuberculosis often have different strains in the same sputum specimen. Am J Respir Crit Care Med 169(5), 610-614.
8. Chan M Y, Borgdorff M, Yip C W, et al. (2001). Seventy percent of the Mycobacterium tuberculosis isolates in Hong Kong represent the Beijing genotype. Epidemiol Infect 127(1), 169-171.
9. Lipin M Y, Stepanshina V N, Shemyakin I G, et al. (2007). Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia. Clin Microbiol Infect 13(6), 620-626.
10. Mokrousov I, Otten T, Vyazovaya A, et al. (2003). PCR-based methodology for detecting multidrug-resistant strains of Mycobacterium tuberculosis Beijing family circulating in Russia. Eur J Clin Microbiol Infect Dis 22(6), 342-348.
11. Yue J, Shi W, Xie J, et al. (2003). Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from China. J Clin Microbiol 41(5), 2209-2212.
12. Chan R C, Hui M, Chan E W, et al. (2007). Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J Antimicrob Chemother 59(5), 866-873.
13. Hillemann D, Weizenegger M, Kubica T, et al. (2005). Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. J Clin Microbiol 43(8), 3699-3703.
14. Abbadi S, Rashed H G, Morlock G P, et al. (2001). Characterization of IS6110 restriction fragment length polymorphism patterns and mechanisms of antimicrobial resistance for multidrug-resistant isolates of Mycobacterium tuberculosis from a major reference hospital in Assiut, Egypt. J Clin Microbiol 39(6), 2330-2334.
15. Bartfai Z, Somoskovi A, Kodmon C, et al. (2001). Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J Clin Microbiol 39(10), 3736-3739.
16. Guo J H, Xiang W L, Zhao Q R, et al. (2008). Molecular characterization of drug-resistant mycobacterium tuberculosis isolates from Sichuan Province in China. Jpn J Infect Dis 61(4), 264-268.
17. Hirano K, Abe C, Takahashi M. (1999). Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J Clin Microbiol 37(8), 2663-2666.
18. Hwang H Y, Chang C Y, Chang L L, et al. (2003). Characterization of rifampicin-resistant Mycobacterium tuberculosis in Taiwan. J Med Microbiol 52(Pt 3), 239-245.
19. Hazbon M H, Brimacombe M, Bobadilla del Valle M, et al. (2006). Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 50(8), 2640-2649.
20. Sekiguchi J, Miyoshi-Akiyama T, Augustynowicz-Kopec E, et al. (2007). Detection of multidrug resistance in Mycobacterium tuberculosis. J Clin Microbiol 45(1), 179-92.
21. Nikolayevsky V, Brown T, Balabanova Y, et al. (2004). Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation. J Clin Microbiol 42(10), 4498-4502.
22. Taniguchi H (2000). Molecular mechanisms of multidrug resistance in Mycobacterium tuberculosis. J UOEH 22(3), 269-282.
23. Banerjee A, Sugantino M, Sacchettini J C, et al. (1998). The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance. Microbiology 144 ( Pt 10), 2697-2704.
24. Zhang M, Yue J, Yang Y P, et al. (2005). Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China. J Clin Microbiol 43(11), 5477-5482.
25. Mokrousov I, Narvskaya O, Otten T, et al. (2002). High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001. Antimicrob Agents Chemother 46(5), 1417-1424.
26. van Soolingen D, de Haas P E, van Doorn H R, et al. (2000). Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. J Infect Dis 182(6), 1788-1790.
27. Lavender C, Globan M, Sievers A, et al. (2005). Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia. Antimicrob Agents Chemother 49(10), 4068-4074.
28. Valvatne H, Syre H, Kross M, et al. (2009). Isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing. J Antimicrob Chemother 64(4), 694-701.
29. Lee A S, Teo A S, Wong S Y (2001). Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 45(7), 2157-2159.
30. Siddiqi N, Das R, Pathak N, et al. (2004). Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a tap-like efflux pump. Infection 32(2), 109-111.
31. Finken M, Kirschner P, Meier A, et al. (1993). Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol Microbiol 9(6), 1239-1246.
32. Fukuda M, Koga H, Ohno H, et al. (1999). Relationship between genetic alteration of the rpsL gene and streptomycin susceptibility of Mycobacterium tuberculosis in Japan. J Antimicrob Chemother 43(2), 281-284.
33. Gegia M, Mdivani N, Mendes R E, et al. (2008). Prevalence of and molecular basis for tuberculosis drug resistance in the Republic of Georgia: validation of a QIAplex system for detection of drug resistance-related mutations. Antimicrob Agents Chemother 52(2), 725-729.
34. Honore N, Cole S T (1994). Streptomycin resistance in mycobacteria. Antimicrob Agents Chemother 38(2), 238-242.
35. Meier A, Kirschner P, Bange F C, et al. (1994). Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance. Antimicrob Agents Chemother 38(2), 228-233.
36. Ainsa J A, Blokpoel M C, Otal I, et al. (1998). Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis. J Bacteriol 180(22), 5836-5843.
37. Choudhuri B S, Bhakta S, Barik R, et al. (2002). Overexpression and functional characterization of an ABC (ATP-binding cassette) transporter encoded by the genes drrA and drrB of Mycobacterium tuberculosis. Biochem J 367(Pt 1), 279-285.
38. Starks A M, Gumusboga A, Plikaytis B B, et al. (2009). Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 53(3), 1061-1066.
39. Jadaun G P, Das R, Upadhyay P, et al. (2009). Role of embCAB gene mutations in ethambutol resistance in Mycobacterium tuberculosis isolates from India. Int J Antimicrob Agents 33(5), 483-486.
40. Shi R, Zhang J, Otomo K, et al. (2007). Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China. Antimicrob Agents Chemother 51(12), 4515-4517.
41. Hazbon M H, Bobadilla del Valle M, Guerrero M I, et al. (2005). Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob Agents Chemother 49(9), 3794-3802.
42. Mani C, Selvakumar N, Kumar V, et al. (2003). Comparison of DNA sequencing, PCR-SSCP and PhaB assays with indirect sensitivity testing for detection of rifampicin resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 7(7), 652-659.
43. Wu X ZM, Zhang J., Yu W, Zhang J, Zhuang Y, Jia S. (2000). Analysis of katG gene mutations in m tuberculosis isolates by direct sequencing. Lin Chuang Jian Yan Za Zhi 18(1), 9-11. (In Chinese)
44. Sreevatsan S, Pan X, Stockbauer K E, et al. (1996). Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities. Antimicrob Agents Chemother 40(4), 1024-1026.
45. Parsons L M, Salfinger M, Clobridge A, et al. (2005). Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol. Antimicrob Agents Chemother 49(6), 2218-2225.